2025年达利雷生(Daridorexant)最新价格是多少钱一盒？

Introduction: Daridorexant belongs to a class of drugs called orexin receptor antagonists, which work by blocking the action of certain natural substances in the brain that cause awakening, and are used to treat insomnia (difficulty falling asleep or staying asleep). The market price of Dali Resonance varies depending on the region, packaging specifications, and sales channels.

What is the latest price of a box of Daridorexant in 2025?

It is not yet available in the country and cannot be purchased directly in the country. At present, we know that the specification of DaliRasen produced by Idorsia Ltd/Switzerland Alschwil Company is 50mg*20 tablets/box, and the price of a box is about US$404.

It is also necessary to consider factors such as region, purchasing channel, packaging specifications, whether there are promotional activities, exchange rate changes, etc. When purchasing, patients are advised to compare multiple parties and choose regular channels to purchase to ensure the quality of the drug.

For patients, when purchasing DaliRasen, it is recommended to give priority to regular channels, such as hospital pharmacies, large chain pharmacies or officially authorized pharmaceutical e-commerce platforms. In addition, patients can also pay attention to drug promotions to obtain more favorable prices. At the same time, patients should also pay attention to check the packaging, expiration date, production batch number and other information of the medicine when purchasing to ensure the quality of the medicine purchased.

Usage and dosage of Daridorexant

Daridorexant is an oral tablet mainly used to treat insomnia in adults. Its usage and dosage vary depending on individual patient differences and the severity of the condition. Generally speaking, the recommended dose for adult patients is to take it orally once every night within 30 minutes before going to bed, and the dose range is 25mg-50mg.

For patients who are using it for the first time, it is recommended to start with a low dose and gradually adjust to the optimal dose. At the same time, patients should follow the doctor's advice when using DaliRasen, use it in strict accordance with the usage and dosage on the drug instructions, and avoid excessive or reduced dosage.

The efficacy evaluation of DaliRasen is usually based on the patient's sleep quality, time to fall asleep, sleep maintenance time, and daytime function and other indicators. Patients should regularly evaluate the efficacy while using DaliRasen. If the efficacy is poor or severe side effects occur, they should seek medical treatment promptly and adjust the treatment plan.

Usage of Daridorexant in special populations

1. For pregnant and lactating women, there is currently no specific data on the use of Daridorexant in humans during pregnancy and lactation, and its related risks cannot be accurately assessed.因此，孕妇和哺乳期妇女应在医生指导下使用达利雷生，并权衡利弊。

2. For the elderly, there is usually no need to adjust the dosage of DaliRasen. However, elderly patients have a higher risk of falling after taking this drug, so they should be closely monitored during use.

3. For patients with liver damage, the use of DaliRasen requires special caution. For patients with severe hepatic impairment, it is not recommended to use DaliRasen. For patients with moderate hepatic impairment, it should be used under the guidance of a doctor, and the dose may need to be reduced.

4. For patients with narcolepsy, the use of DaliRasen may further aggravate symptoms, such as increasing the frequency and duration of sleep attacks, and even leading to more severe sleep disorders. Therefore, patients with narcolepsy should not use Dalitrazolin.